Robeco Institutional Asset Management B.V. United Therapeutics Corp Transaction History

Robeco Institutional Asset Management B.V.

  • $60.3 Billion
  • Q2 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in United Therapeutics Corp stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 234,639 shares of UTHR stock, worth $106 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
234,639
Previous 226,287 3.69%
Holding current value
$106 Million
Previous $69.8 Million 3.35%
% of portfolio
0.11%
Previous 0.14%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025
BUY
$276.47 - $328.4 $2.31 Million - $2.74 Million
8,352 Added 3.69%
234,639 $67.4 Million
Q1 2025

Apr 23, 2025
BUY
$304.42 - $380.78 $10.5 Million - $13.1 Million
34,362 Added 17.9%
226,287 $69.8 Million
Q4 2024

Jan 22, 2025
SELL
$348.66 - $410.0 $1.43 Million - $1.68 Million
-4,094 Reduced 2.09%
191,925 $67.7 Million
Q3 2024

Oct 29, 2024
BUY
$311.04 - $363.55 $2.13 Million - $2.49 Million
6,839 Added 3.62%
196,019 $70.2 Million
Q2 2024

Jul 22, 2024
BUY
$228.26 - $319.04 $2.08 Million - $2.91 Million
9,114 Added 5.06%
189,180 $60.3 Million
Q1 2024

Apr 24, 2024
BUY
$210.76 - $249.51 $20 Million - $23.7 Million
94,993 Added 111.66%
180,066 $41.4 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $5.38 Million - $6.43 Million
25,037 Added 41.7%
85,073 $18.7 Million
Q4 2023

Feb 08, 2024
SELL
$214.88 - $256.94 $5.8 Million - $6.94 Million
-27,012 Reduced 31.03%
60,036 $85.1 Million
Q3 2023

Oct 23, 2023
BUY
$211.82 - $248.24 $10.3 Million - $12 Million
48,397 Added 125.22%
87,048 $19.7 Million
Q2 2023

Jul 24, 2023
SELL
$205.19 - $232.99 $8.09 Million - $9.19 Million
-39,449 Reduced 50.51%
38,651 $8.53 Million
Q1 2023

May 03, 2023
BUY
$212.99 - $276.17 $14.9 Million - $19.4 Million
70,101 Added 876.37%
78,100 $17.5 Million
Q4 2022

Feb 06, 2023
BUY
$205.95 - $280.43 $1.31 Million - $1.78 Million
6,352 Added 385.67%
7,999 $2.22 Million
Q3 2022

Dec 01, 2022
SELL
$203.3 - $244.17 $195,777 - $235,135
-963 Reduced 36.9%
1,647 $345,000
Q3 2022

Oct 26, 2022
SELL
$203.3 - $244.17 $195,777 - $235,135
-963 Reduced 36.9%
1,647 $345,000
Q2 2022

Dec 01, 2022
SELL
$174.81 - $241.14 $2.57 Million - $3.55 Million
-14,716 Reduced 84.94%
2,610 $615,000
Q2 2022

Jul 27, 2022
SELL
$174.81 - $241.14 $2.57 Million - $3.55 Million
-14,716 Reduced 84.94%
2,610 $615,000
Q1 2022

Dec 01, 2022
SELL
$166.16 - $213.96 $46.5 Million - $59.9 Million
-280,001 Reduced 94.17%
17,326 $3.11 Million
Q1 2022

Apr 26, 2022
SELL
$166.16 - $213.96 $46.5 Million - $59.9 Million
-280,001 Reduced 94.17%
17,326 $3.11 Million
Q4 2021

Dec 01, 2022
SELL
$184.32 - $216.08 $11.9 Million - $13.9 Million
-64,546 Reduced 17.84%
297,327 $64.2 Million
Q4 2021

Jan 31, 2022
SELL
$184.32 - $216.08 $11.9 Million - $13.9 Million
-64,546 Reduced 17.84%
297,327 $64.2 Million
Q3 2021

Dec 01, 2022
SELL
$179.86 - $214.88 $2.72 Million - $3.25 Million
-15,118 Reduced 4.01%
361,873 $66.8 Million
Q3 2021

Oct 20, 2021
SELL
$179.86 - $214.88 $2.72 Million - $3.25 Million
-15,118 Reduced 4.01%
361,873 $66.8 Million
Q2 2021

Dec 01, 2022
SELL
$170.47 - $211.93 $9.67 Million - $12 Million
-56,698 Reduced 13.07%
376,991 $67.6 Million
Q2 2021

Jul 28, 2021
SELL
$170.47 - $211.93 $9.67 Million - $12 Million
-56,698 Reduced 13.07%
376,991 $67.6 Million
Q1 2021

Dec 01, 2022
BUY
$153.94 - $174.85 $66.5 Million - $75.5 Million
432,042 Added 26232.06%
433,689 $72.5 Million
Q1 2021

Apr 23, 2021
SELL
$153.94 - $174.85 $8.09 Million - $9.19 Million
-52,546 Reduced 10.81%
433,689 $72.5 Million
Q4 2020

Dec 01, 2022
BUY
$101.87 - $151.79 $49.4 Million - $73.6 Million
484,588 Added 29422.47%
486,235 $73.8 Million
Q4 2020

Jan 28, 2021
SELL
$101.87 - $151.79 $2.73 Million - $4.07 Million
-26,830 Reduced 5.23%
486,235 $73.8 Million
Q3 2020

Oct 29, 2020
SELL
$99.9 - $121.13 $1.12 Million - $1.36 Million
-11,192 Reduced 2.13%
513,065 $51.8 Million
Q2 2020

Jul 20, 2020
BUY
$92.74 - $125.82 $47.3 Million - $64.1 Million
509,645 Added 3487.85%
524,257 $63.4 Million
Q1 2020

Apr 30, 2020
BUY
$79.39 - $115.35 $1.16 Million - $1.69 Million
14,612 New
14,612 $1.39 Million
Q4 2019

Feb 06, 2020
SELL
$78.31 - $95.34 $474,167 - $577,283
-6,055 Closed
0 $0
Q3 2019

Oct 17, 2019
SELL
$74.85 - $85.99 $1.97 Million - $2.26 Million
-26,253 Reduced 81.26%
6,055 $483,000
Q2 2019

Jul 19, 2019
SELL
$76.06 - $120.81 $28.1 Million - $44.7 Million
-369,851 Reduced 91.97%
32,308 $2.52 Million
Q1 2019

May 02, 2019
BUY
$107.15 - $126.84 $8.9 Million - $10.5 Million
83,037 Added 26.02%
402,159 $47.2 Million
Q4 2018

Feb 08, 2019
SELL
$101.4 - $128.73 $628,173 - $797,482
-6,195 Reduced 1.9%
319,122 $34.5 Million
Q3 2018

Oct 25, 2018
BUY
$113.81 - $129.46 $7.4 Million - $8.42 Million
65,049 Added 24.99%
325,317 $41.6 Million
Q2 2018

Aug 03, 2018
BUY
$101.14 - $118.31 $792,634 - $927,195
7,837 Added 3.1%
260,268 $29.4 Million
Q1 2018

May 07, 2018
BUY
$107.21 - $151.94 $6.46 Million - $9.15 Million
60,244 Added 31.35%
252,431 $28.4 Million
Q4 2017

Jan 25, 2018
BUY
$118.58 - $151.28 $4.01 Million - $5.12 Million
33,819 Added 21.35%
192,187 $28.4 Million
Q3 2017

Oct 17, 2017
BUY
$114.6 - $136.81 $3.28 Million - $3.92 Million
28,625 Added 22.06%
158,368 $18.6 Million
Q2 2017

Aug 08, 2017
BUY
N/A
23,239 Added 21.82%
129,743 $16.8 Million
Q1 2017

Jan 19, 2021
BUY
N/A
106,504
106,504 $14.4 Million

Others Institutions Holding UTHR

# of Institutions
745
Shares Held
44.1M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $20.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email